Scientific publication

Scientific publication in the area of industrial enzymes. A novel proteinase Onygena, an improved alternative to the ‘workhorse’ of molecular biology – proteinase K has been cloned, expressed and characterised as a result of cooperation with Barentzymes AS, a Norwegian biotechnology company (part of Fluenta holding). The results have been published in high rank journal Microbial Cell Factories (IF = 4.6) and protected by EU patent application. The Onygena proteinase is more active and works at lower temperaturę tan proteinase K, thus is uniquelly suited as an enzymatic tools for waste utilization, environment pollution control, protein sequencing, removal and analysis (Microb Cell Fact (2020) 19:135).

An alternative for proteinase K‑heat‑sen

.

Download • 1.90MB

Patent for Israel

We have been informed by Israeli Patent Office that our patent application no 248011, concerning our break-through recombinant DNA biotechnology for the construction of a new generation vaccines, biologics, biosimilars, industrial and environmental processes is being processed. We are awaiting for further decisions.

Patent for Japan

Our break-through recombinant DNA biotechnology for the construction of a new generation vaccines, biologics, biosimilars, industrial and environmental processes has been granted with Japanese patent no P6692796.

Patent no.6692796

.pdf

Download PDF • 1.46MB

.